Paget's Disease (PD) is the most exaggerated example of coupled bone remodeling with focal areas of increased bone resorption accompanied by exuberant new bone formation. The excessive new bone formation results in deposition of weak woven bone, which is responsible for many of the clinical sequelae of PD including bone deformity or fracture, skull thickening, bone pain and nerve root compression. Osteoclasts (OCLs) drive the increased bone formation, because treatments targeting OCLs decrease bone resorption and formation. However, the mechanisms responsible for the increased bone formation in PD are unknown. Genetic and environmental factors contribute to development of PD. The most frequent mutations linked to PD are in the SQSTM1/p62 gene, in particular p62P392L. Mice harboring germline p62P394L(p62 mice), the murine equivalent of human p62P392L, exhibit increased OCLs, but do not develop PD. OCLs from 70% of PD patients express the measles virus nucleocapsid protein (MVNP) gene, and transgenic mice with targeted expression of MVNP to OCLs (MVNP mice) develop OCLs and bone lesions characteristic of PD. Importantly, loss of IL-6 expression in MVNP mice blocked the pagetic OCL formation and increased bone formation in vivo. Thus, expression of environmental factors (e.g., MVNP) in OCLs is required for the development of characteristic bone abnormalities in PD. Recently, we found that MVNP but not p62P394L increases expression of the coupling factors ephrinB2 by OCLs and EphB4 on osteoblasts (OBs), which was mediated by IL-6. These results suggest that MVNP in OCLs induces coupling factors that increase OB activity. Further, MVNP induced expression of IGF1 by OCLs which may further increase bone formation. This proposal will assess the role of MVNP in the abnormal OB activity in PD by testing the hypothesis that MVNP increases OB activity in PD through induction of ephrinB2 on OCLs and EphB4 on OBs, in part through MVNP's up-regulation of IL-6 and IGF1 in OCLs. Thus, we will: 1) Test the hypothesis that MVNP's induction of ephrinB2 and IGF1 in OCLs and EphB4 in OBs increases OB activity. We will determine the effects of modulating ephrinB2/EphB4 and IGF1 levels/activity on the increased OB activity induced by MVNP. We will also determine if MVNP expression in OCLs from p62P392L PD patients increases ephrinB2 and IGF1 in OCLs and enhances their capacity to induce OB differentiation. 2) Test the hypothesis that IL-6 and IGF1 mediate the induction of ephrinB2 and EphB4 by MVNP. We will determine the mechanisms responsible for IL-6's induction of ephrinB2/ EphB4 by MVNP, and if IGF1 enhances ephrinB2 and/or IL-6 production by OCLs expressing MVNP or simply enhances OB activity via ephrinB2/EphB4. For these studies, we will use cells from MVNP, WT, IL-6-/- and MVNP and WT mice with knockdown of IL-6 or IGF1 in OCLs ex vivo. 3) Generate p62/MVNP mice with targeted deletion of ephrinB2 and/or IGF1 in OCLs and EphB4 in OBs to assess the roles of ephrinB2/EphB4 and IGF1 in the increased OB activity in PD.

Public Health Relevance

Paget's Disease (PD) affects more than 1 million Americans and is the most exaggerated example of coupled bone remodeling with focal areas of increased bone resorption accompanied by exuberant new bone formation. The excessive new bone formation results in formation of woven bone, which is responsible for many of the clinical sequelae of PD, because woven bone is much weaker, can bow and cause bone deformity or fracture, increased skull thickening, bone pain, secondary osteoarthritis and nerve root compression. This proposal will assess the role of MVNP in the abnormal OB activity in PD as means of identifying novel therapeutic targets for enhancing or decreasing osteoblast activity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
2R01AR057308-07A1
Application #
8696548
Study Section
Skeletal Biology Structure and Regeneration Study Section (SBSR)
Program Officer
Sharrock, William J
Project Start
2008-09-15
Project End
2019-04-30
Budget Start
2014-05-08
Budget End
2015-04-30
Support Year
7
Fiscal Year
2014
Total Cost
$369,495
Indirect Cost
$109,250
Name
Indiana University-Purdue University at Indianapolis
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Sun, Quanhong; Sammut, Benedicte; Wang, Feng-Ming et al. (2014) TBK1 mediates critical effects of measles virus nucleocapsid protein (MVNP) on pagetic osteoclast formation. J Bone Miner Res 29:90-102
Teramachi, Jumpei; Zhou, Hua; Subler, Mark A et al. (2014) Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone. J Bone Miner Res 29:1456-65
Bon, Jessica; Kahloon, Rehan; Zhang, Yingze et al. (2014) Autoreactivity to glucose regulated protein 78 links emphysema and osteoporosis in smokers. PLoS One 9:e105066
Storti, P; Bolzoni, M; Donofrio, G et al. (2013) Hypoxia-inducible factor (HIF)-1? suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction. Leukemia 27:1697-706
Wang, Feng-Ming; Sarmasik, Aliye; Hiruma, Yuko et al. (2013) Measles virus nucleocapsid protein, a key contributor to Paget's disease, increases IL-6 expression via down-regulation of FoxO3/Sirt1 signaling. Bone 53:269-76
Kurihara, Noriyoshi; Hiruma, Yuko; Yamana, Kei et al. (2011) Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease. Cell Metab 13:23-34